Penile Implants Global Market Report 2025

Penile implants are medical devices surgically inserted into the penis to treat erectile dysfunction (ED) when other treatments, such as medication or therapy, have been ineffective. Available in inflatable or malleable designs, these implants provide a reliable solution by allowing men to achieve and sustain an erection, thereby enhancing their sexual function and overall quality of life.

The primary types of penile implants include inflatable penile implants, malleable penile implants, and semi-rigid penile implants. Inflatable penile implants are devices implanted into the penis to help men with erectile dysfunction achieve and maintain an erection. This is done by using a pump to transfer fluid into cylinders placed within the penis. Penile implants are intended for patients experiencing vascular, psychogenic, or neurological impotence. They are typically made from materials such as silicone, bioflex, and others. The implantation process can be done through both outpatient and inpatient procedures, with end users including hospitals, ambulatory surgery centers, urology centers, and other medical facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The penile implants market research report is one of a series of new reports from The Business Research Company that provides penile implants market statistics, including penile implants industry global market size, regional shares, competitors with penile implants market share, detailed penile implants market segments, market trends and opportunities, and any further data you may need to thrive in the penile implants industry. This penile implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The penile implants market size has grown strongly in recent years. It will grow from $1.93 billion in 2024 to $2.11 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the rising prevalence of erectile dysfunction (ED), aging global population, increasing incidence of conditions like diabetes, rising cases of hypertension, and increasing prevalence of cardiovascular disease.

The penile implants market size is expected to see strong growth in the next few years. It will grow to $3.05 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the growing prevalence of chronic diseases, increasing focus on men's health and wellness, increasing research for more innovative and efficient implant devices, growing focus on patient education, and rising demand for long-term solutions. Major trends in the forecast period include a shift towards minimally invasive surgical techniques, the availability of personalized penile implant options (inflatable and malleable), advancements in penile implant design (improved comfort, durability, and functionality), increasing patient satisfaction and acceptance of penile implants, and the adoption of advanced technologies.

The forecast of 9.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. prosthetic access by inflating prices of inflatable penile implants and surgical insertion tools developed in the U.S. and Mexico, resulting in longer wait times for reconstructive surgeries and higher out-of-pocket patient costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of erectile dysfunction (ED) is expected to drive the growth of the penile implants market. ED is the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. The rising rates of erectile dysfunction are influenced by factors such as the aging population, higher incidences of lifestyle-related conditions such as diabetes, obesity, and cardiovascular diseases, psychological factors such as stress and anxiety, and improved awareness and diagnosis due to advancements in healthcare. Penile implants are essential in addressing this growing issue by offering a reliable and effective solution for patients who do not respond to pharmacological treatments, thus improving their quality of life and providing a long-term treatment option for severe cases. For example, in January 2022, ED Clinics, a UK-based group of clinicians, reported that between 40% and 55% of men aged 40 to 70, or approximately 4.3 million men in the UK, experience erectile dysfunction. Global cases are projected to increase from 152 million in 1995 to 322 million by 2025. As such, the rising prevalence of ED is a key driver of the penile implants market.

The growing awareness and acceptance of sexual health are expected to further propel the growth of the penile implants market. Sexual health refers to a state of well-being that encompasses physical, emotional, mental, and social aspects of sexuality, promoting respect, safety, and informed decision-making. Increasing awareness of sexual health is crucial for empowering individuals, reducing stigma, improving health outcomes, and encouraging responsible, informed choices regarding sexual well-being. Penile implants play a significant role in raising awareness and acceptance of sexual health by providing long-term solutions for erectile dysfunction, fostering open discussions, reducing stigma, and encouraging individuals to seek medical help for sexual issues. For instance, in July 2024, the UK Health Security Agency reported a 5.0% increase in consultations by Sexual Health Services (SHS) in England in 2023 compared to the previous year, with face-to-face consultations rising by 7.9% and online consultations increasing by 7.5%. As a result, the rising awareness and acceptance of sexual health are driving the growth of the penile implants market.

Key players in the penile implants market are focusing on developing innovative products, such as penile prosthesis pumps, to improve both patient and physician experiences. These pumps enhance the reliability, ease of use, and post-operative training for inflatable penile prostheses. A penile prosthesis pump is a device implanted in the scrotum that enables users to create an erection by manually pumping fluid from a reservoir into inflatable cylinders in the penis. For example, in November 2023, Boston Scientific, a US-based medical technology company, received FDA approval for its Tenacio pump, a component of the AMS 700 inflatable penile prosthesis (IPP). The Tenacio pump features automation that allows for automatic deflation with the press of a button, addressing issues such as stiction syndrome and improving usability. This innovation simplifies device training for patients, potentially reducing the learning curve and saving time for physicians during post-operative orientations.

Major players in the penile implants market are Bristol Myers Co., Medline Industries, Boston Scientific Corporation, Coloplast Corp, Hollister Incorporated, Fortis Healthcare, Noble Healthcare, SILIMED, Medscape Ltd., Promedon S.A., Zephyr Surgical Implants, Augmenta LLC, Rigicon Inc, Advin Health Care, Penuma, Vacurect, Shah Prosthesis, LipoMatrix Inc., Kirch Urologie BV, and Milux Holding SA.

North America was the largest region in the penile implants market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in penile implants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the penile implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The penile implants market consists of sales of hydrogel implants, titanium implants, smart implants, and customizable implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Penile Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on penile implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for penile implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The penile implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Implant Type: Inflatable Penile Implants; Malleable Penile Implants; Semi-Rigid Penile Implants
• 2) By Patient Type: Vascular Impotence Patients; Psychogenic Impotence Patients; Neurological Impotence Patients
• 3) By Material: Silicon; Bioflex; Other Materials
• 4) By Deployment Method: Outpatient Procedure; Inpatient Procedure
• 5) By End User: Hospital; Ambulatory Surgery Centers; Urology Centers; Other End Users
• Subsegments:
• 1) By Inflatable Penile Implants: Two-Piece Inflatable Penile Implants; Three-Piece Inflatable Penile Implants
• 2) By Malleable Penile Implants: Single-Component Malleable Implants; Multi-Component Malleable Implants
• 3) By Semi-Rigid Penile Implants: Semi-Rigid Rod Implants; Semi-Rigid Adjustable Implants
• Companies Mentioned: Bristol Myers Co.; Medline Industries; Boston Scientific Corporation; Coloplast Corp; Hollister Incorporated; Fortis Healthcare; Noble Healthcare; SILIMED; Medscape Ltd.; Promedon S.A.; Zephyr Surgical Implants; Augmenta LLC; Rigicon Inc; Advin Health Care; Penuma; Vacurect; Shah Prosthesis; LipoMatrix Inc.; Kirch Urologie BV; Milux Holding SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.